Joon‐Yong Chung

8.8k total citations
175 papers, 4.4k citations indexed

About

Joon‐Yong Chung is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Joon‐Yong Chung has authored 175 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 45 papers in Oncology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Joon‐Yong Chung's work include Advanced Biosensing Techniques and Applications (16 papers), Molecular Biology Techniques and Applications (14 papers) and Cancer Cells and Metastasis (14 papers). Joon‐Yong Chung is often cited by papers focused on Advanced Biosensing Techniques and Applications (16 papers), Molecular Biology Techniques and Applications (14 papers) and Cancer Cells and Metastasis (14 papers). Joon‐Yong Chung collaborates with scholars based in United States, South Korea and Japan. Joon‐Yong Chung's co-authors include Stephen M. Hewitt, Hanbyoul Cho, Jae‐Hoon Kim, Kris Ylaya, Till Braunschweig, Chel Hun Choi, Eun Joo Chung, Seung‐Mo Hong, Yoon Kong and Tae Woo Kim and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Joon‐Yong Chung

170 papers receiving 4.3k citations

Peers

Countries citing papers authored by Joon‐Yong Chung

Since Specialization

Citations

This map shows the geographic impact of Joon‐Yong Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joon‐Yong Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joon‐Yong Chung more than expected).

Fields of papers citing papers by Joon‐Yong Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joon‐Yong Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joon‐Yong Chung. The network helps show where Joon‐Yong Chung may publish in the future.

Co-authorship network of co-authors of Joon‐Yong Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Joon‐Yong Chung. A scholar is included among the top collaborators of Joon‐Yong Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joon‐Yong Chung. Joon‐Yong Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion 2024 ·Nature Communications ·Hyunjin Rho, Seung‐Yeon Kim, Seung Up Kim, Jeong Won Kim, Sang Hoon Lee, Sanghoon Park, Freddy E. Escorcia, Joon‐Yong Chung, Jaewhan Song	4
2	Successful lung transplantation using an allograft from a COVID-19–recovered donor: a potential role for subgenomic RNA to guide organ utilization 2023 ·American Journal of Transplantation ·Kapil Saharia, Sabrina Ramelli, Sydney Stein, Allison Roder, (unknown), Stephanie Banakis, Joon‐Yong Chung, Peter D. Burbelo, Manmeet Singh, Robert M. Reed, Vipul Patel, Joseph Rabin, Alexander S. Krupnick, Jeffrey I. Cohen, Emmie de Wit, Elodie Ghedin, Stephen M. Hewitt, Kevin M. Vannella, Daniel S. Chertow, Alison Grazioli	6
3	Human Neuralized is a novel tumour suppressor targeting Wnt/β‐catenin signalling in colon cancer 2023 ·EMBO Reports ·Joo Mi Yi, Tae‐Hong Kang, Yu Han, Ha Young Park, Ju Hwan Yang, (unknown), (unknown), Tae‐Jin Kim, Joong‐Gook Kim, Yan‐Hong Cui, Hiromu Suzuki, (unknown), Sung Joo Kim, Yi Zhao, In Ja Park, Seung‐Mo Hong, Joon‐Yong Chung, Su‐Jae Lee	5
4	Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer 2023 ·Frontiers in Oncology ·Jiwon Ryu, (unknown), Hyosun Kim, Gwan Hee Han, Jeong Won Kim, (unknown), Hanbyoul Cho, Joon‐Yong Chung, Jae‐Hoon Kim	0
5	Selective ablation of TRA-1-60⁺ pluripotent stem cells suppresses tumor growth of prostate cancer 2023 ·Theranostics ·(unknown), (unknown), (unknown), Joon‐Yong Chung, (unknown), (unknown), (unknown), (unknown), (unknown), Steve M. Patrick, Seongho Kim, Elisabeth I. Heath, Freddy E. Escorcia, Nerissa T. Viola	2
6	Single‐cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC 2022 ·Hepatology ·Subreen A. Khatib, Lichun Ma, Hien Dang, Marshonna Forgues, Joon‐Yong Chung, Kris Ylaya, Stephen M. Hewitt, Jittiporn Chaisaingmongkol, (unknown), Xin Wei Wang	14
7	The interferon-inducible protein viperin controls cancer metabolic reprogramming to enhance cancer progression 2022 ·Journal of Clinical Investigation ·(unknown), Jeong Jin Kim, (unknown), (unknown), (unknown), (unknown), Haengdueng Jeong, Kyungeun Kim, Ki Taek Nam, Young Soo Park, Joon‐Yong Chung, Jun-Young Seo	27
8	Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury 2022 ·PLoS ONE ·(unknown), Teruhiko Yoshida, Clark M. Henderson, (unknown), (unknown), Joshua A. Lieberman, Ian H. de Boer, Tomáš Vaisar, Jonathan Himmelfarb, Bryan Kestenbaum, Joon‐Yong Chung, Stephen M. Hewitt, (unknown), Brandon Ginley, Pinaki Sarder, Avi Z. Rosenberg, Taichi Murakami, Jeffrey B. Kopp, Zsuzsanna Kuklenyik, Andrew N. Hoofnagle	4
9	HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule 2022 ·PLoS ONE ·Shashi Shrivastav, Hewang Lee, (unknown), Huiyan Lü, Teruhiko Yoshida, (unknown), Hidefumi Wakashin, (unknown), Erik H. Koritzinsky, Peng Xu, Laureano D. Asico, Joon‐Yong Chung, Stephen M. Hewitt, John J Gildea, Robin A. Felder, Pedro A. José, Avi Z. Rosenberg, Mark A. Knepper, Tomoshige Kino, Jeffrey B. Kopp	0
10	Quality Assessment of Proteins and RNA Following Storage in Archival Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissue Microarray Sections 2022 ·Biopreservation and Biobanking ·Kyungeun Kim, Kris Ylaya, Candice Perry, Mi Yeon Lee, Jeong Won Kim, Joon‐Yong Chung, Stephen M. Hewitt	4
11	MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors 2021 ·PLoS Pathogens ·(unknown), Rosa T. Sterk, (unknown), Joon‐Yong Chung, Kiersten L. Berggren, (unknown), (unknown), Andrew T. Cowan, Gregory N. Gan, Emrullah Yilmaz, Hanbyoul Cho, Jae‐Hoon Kim, Stephen M. Hewitt, Julie E. Bauman, Michelle A. Ozbun	25
12	Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma 2020 ·Molecular Oncology ·(unknown), Wookyeom Yang, Doo Byung Chay, (unknown), Joon‐Yong Chung, Hyun Soo Kim, Jae‐Hoon Kim	17
13	LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells 2020 ·Autophagy ·Suyeon Kim, Hanbyoul Cho, (unknown), Se Jin Oh, Hyo-Jung Lee, Eunho Cho, Seon Rang Woo, Joon Seon Song, Joon‐Yong Chung, (unknown), Sang Min Yoon, (unknown), Seunghyun Jeon, Cassian Yee, Kyung‐Mi Lee, Stephen M. Hewitt, Jae‐Hoon Kim, Kwon‐Ho Song, Tae Woo Kim	41
14	The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer 2020 ·International Journal of Gynecological Pathology ·Gwan Hee Han, Doo Byung Chay, (unknown), Hanbyoul Cho, Joon‐Yong Chung, Jae‐Hoon Kim	12
15	Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3–NANOG Axis 2018 ·Cancer Research ·Se Jin Oh, Hanbyoul Cho, Suhyun Kim, Kyung Hee Noh, Kwon‐Ho Song, Hyo-Jung Lee, Seon Rang Woo, Suyeon Kim, Chel Hun Choi, Joon‐Yong Chung, Stephen M. Hewitt, Jae‐Hoon Kim, Seung‐Ki Baek, Kyung‐Mi Lee, Cassian Yee, Hae‐Chul Park, Tae Woo Kim	29
16	HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells 2017 ·Cancer Research ·Kwon‐Ho Song, Chel Hun Choi, Hyo‐Jung Lee, Se Jin Oh, Seon Rang Woo, (unknown), Kyung Hee Noh, Hanbyoul Cho, Eun Joo Chung, Jae‐Hoon Kim, Joon‐Yong Chung, Stephen M. Hewitt, Seung‐Ki Baek, Kyung‐Mi Lee, Cassian Yee, (unknown), Chih‐Ping Mao, T.‐C. Wu, Tae Woo Kim	72
17	A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Guangjing Zhu, Zhi Liu, Jonathan I. Epstein, Christine Davis, Christhunesa S. Christudass, (unknown), Patricia Landis, Hui Zhang, Joon‐Yong Chung, Stephen M. Hewitt, Michael Craig Miller, Robert W. Veltri	13
18	MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer 2014 ·BMC Cancer ·Hanbyoul Cho, Joon‐Yong Chung, Sung‐Hoon Kim, Till Braunschweig, Tae Heung Kang, (unknown), Eun Joo Chung, Stephen M. Hewitt, Jae‐Hoon Kim	70
19	S100A4 expression is a prognostic indicator in small intestine adenocarcinoma 2013 ·Journal of Clinical Pathology ·Jin Roh, Spencer Knight, Joon‐Yong Chung, (unknown), Michael Goggins, Jihoon Kim, HyungJun Cho, Eunsil Yu, Seung‐Mo Hong	10
20	Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer 2011 ·Molecular Cancer Research ·(unknown), (unknown), Soojin Lee, (unknown), Kathleen D. Whitney, Joon‐Yong Chung, Stephen M. Hewitt, Gloria S. Huang, Gary L. Goldberg, Steven K. Libutti, Mijung Kwon	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact